Analyst firms · Citigroup · TDOC
Citigroup TDOC price target and rating history
Teladoc Health Inc. (TDOC) · Health Care
Citigroup rates Teladoc Health Inc. (TDOC) Neutral with a $43 price target, as of its latest action on Apr 28, 2022. It has published 3 rating actions on TDOC since October 2021, including 0 upgrades and 1 downgrade. Across 4 firms with a TDOC price target in the last 12 months, the median target is $8.25.
- Current rating
- Neutral
- Price target
- $43
- Median target, all firms
- $8.25
- Actions on TDOC
- 3
Citigroup price target on TDOC
Every Citigroup rating on TDOC
- Apr 28, 2022
- Nov 19, 2021
- Oct 28, 2021
How other firms rate TDOC
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Argus Research | Sell | Nov 2, 2026 | |
| Deutsche Bank | Buy | $11 | Mar 10, 2026 |
| BofA Securities | Buy | $7 | Feb 26, 2026 |
| Barclays | Equal Weight | $8.50 | Dec 9, 2025 |
| BMO Capital Markets | Market Perform | $8 | Nov 13, 2025 |
Questions about Citigroup and TDOC
- What is Citigroup's price target for TDOC?
- Citigroup's latest stated price target for Teladoc Health Inc. (TDOC) is $43, from its action on Apr 28, 2022.
- What is Citigroup's rating on TDOC?
- Citigroup rates TDOC Neutral, a neutral rating, as of Apr 28, 2022.
- When did Citigroup last change its view on TDOC?
- On Apr 28, 2022, Citigroup downgrades to Neutral from Buy, price target $115 to $43.
- How does Citigroup's TDOC target compare with other analysts?
- Across 4 firms with a TDOC price target in the last 12 months, the median target is $8.25.
More TDOC rating histories
- Argus Research4
- Deutsche Bank4
- BofA Securities4
- Barclays4
- Goldman Sachs4
- Jefferies3
- Leerink Partners7
- Guggenheim4
- KeyBanc Capital Markets3
- Needham4
- Wells Fargo3
- Credit Suisse4
- Piper Sandler3
- Oppenheimer4
All Citigroup ratingsTDOC news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.